CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
2.190
-0.085 (-3.75%)
Apr 2, 2026, 10:49 AM EDT - Market open
CNS Pharmaceuticals Market Cap
CNS Pharmaceuticals has a market cap or net worth of $1.36 million as of April 2, 2026. Its market cap has decreased by -74.48% in one year.
Market Cap
1.36M
Enterprise Value
-8.47M
1-Year Change
-74.48%
Ranking
Category
Stock Price
$2.19
Market Cap Chart
Since November 8, 2019, CNS Pharmaceuticals's market cap has decreased from $69.92M to $1.36M, a decrease of -98.06%. That is a compound annual growth rate of -45.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 1.41M | -56.66% |
| Dec 31, 2025 | 3.26M | -52.95% |
| Dec 31, 2024 | 6.92M | 4.40% |
| Dec 29, 2023 | 6.63M | 109.26% |
| Dec 30, 2022 | 3.17M | -83.83% |
| Dec 31, 2021 | 19.60M | -51.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Propanc Biopharma | 2.22M |
| Clearmind Medicine | 2.17M |
| HCW Biologics | 2.07M |
| SciSparc | 2.07M |
| Scinai Immunotherapeutics | 1.98M |
| Bone Biologics | 1.97M |
| Ensysce Biosciences | 1.96M |
| Jaguar Health | 1.68M |